PharVision Advisers’s Bank of N.T. Butterfield & Son NTB Stock Holding History

PharVision Advisers’s Portfolio NTB Stock Details NTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,424	Closed	-$220K	–	473
2025 Q4	$220K	Buy	+4,424	New	+$204K	0.11%	478
2025 Q2	–	Sell	-10,456	Closed	-$407K	–	377
2025 Q1	$407K	Sell	10,456 -2,543	-20%	-$96.2K	0.56%	32
2024 Q4	$475K	Buy	+12,999	New	+$487K	0.4%	48

Other funds holding NTB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RIM

Rovida Investment Management Grand Cayman, Cayman Islands $1.47B AUM 142.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

PharVision Advisers's NTB Position: Q1 2026 in Review

PharVision Advisers sold out of Bank of N.T. Butterfield & Son (NTB) in Q1 2026, closing a stake of 4,424 shares — an estimated $220K sold.

PharVision Advisers first reported a position in NTB in Q4 2024 and held it in 3 quarters. The position peaked at $475K in Q4 2024. 245 funds tracked by Wall St. Rank hold NTB as of Q1 2026.

PharVision Advisers reported no remaining Bank of N.T. Butterfield & Son position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,424 Bank of N.T. Butterfield & Son shares in Q1 2026, an estimated $220K.
PharVision Advisers first reported a position in Bank of N.T. Butterfield & Son in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Bank of N.T. Butterfield & Son position peaked at $475K in Q4 2024.
245 funds tracked by Wall St. Rank held Bank of N.T. Butterfield & Son as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.